celares GmbH brings GMP-production facility into operation
Activated PEG-reagents are important start materials for the manufacturing of PEGylated drugs. By PEGylation the pharmacological properties of drugs are improved and their tolerance by the patient is increased. At its location Berlin-Buch celares GmbH has invested more than one million Euro by own means in the construction of clean rooms and the installation of equipment. Core is a modern 60L reactor for the actual chemical synthesis of the PEG-reagents in a multi-kilogram scale. The complete process is performed according to the current guidelines for Good Manufacturing Praxis (cGMP). In this way the use of these products in the pharmaceutical field is possible.
In addition to the distribution of PEG-reagents for scientific applications, customised development services for pharmaceutical companies have been the main business of celares GmbH so far. Since 2003 the company has successfully developed several PEGylated drugs up to the beginning of clinical development. With the installation of a production facility celares GmbH can now provide PEG-reagents for the full clinical development phase and market supply to existing and new clients. The company expects a significant increase in turn over by this activity and will grow to 25 employees within the next months.
Organizations
Other news from the department manufacturing
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.